# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate cell therapies
- describe regulatory constraints
- limitations of exogenous cell therapies
- introduce intraoperative cell therapies
- limitations of current cell isolation approaches

## SUMMARY OF THE INVENTION

- introduce invention
- describe device for enriching cells
- describe method for enriching cells
- specify cell surface marker
- describe aptamer-coupled beads
- describe release of cells
- describe production of enriched cell population
- specify CD31+ cells
- describe therapeutic use of CD31+ cells
- describe device components
- describe aptamer coupling
- describe bead size
- describe aptamer concentration
- describe device configuration
- describe method steps
- describe washing step
- describe mechanical force
- describe cell recovery
- describe cell population enrichment
- describe administration of enriched cells
- describe kit for cell enrichment

## DETAILED DESCRIPTION OF THE INVENTION

- introduce cell enrichment device
- describe aptamer-based cell enrichment
- define terms used in the invention
- describe CD31+ cells and their characteristics
- discuss limitations of traditional cell purification methods
- introduce aptamer-based cell enrichment method
- describe advantages of aptamer-based cell enrichment
- provide example of bone healing application
- describe CD31+ cells in bone healing
- discuss importance of rapid cell enrichment
- describe aptamer characteristics
- discuss advantages of aptamers over antibodies
- describe SELEX method for generating aptamers
- discuss counter-SELEX method for improving aptamer specificity
- describe tag and probe components for aptamer immobilization

### I. CD31+ Cells

- introduce CD31+ cells
- describe CD31+ cell characteristics
- discuss CD31+ cell functions
- describe CD31+ cell sources
- discuss traditional methods for purifying CD31+ cells
- describe limitations of traditional methods
- introduce aptamer-based method for purifying CD31+ cells

### II. Aptamers

- introduce aptamers
- describe aptamer characteristics
- discuss advantages of aptamers
- describe aptamer binding to cell surface markers
- introduce SELEX method for generating aptamers
- describe SELEX process
- discuss counter-SELEX method for improving aptamer specificity
- describe aptamer synthesis
- discuss aptamer stability
- describe aptamer binding affinity
- discuss aptamer advantages over antibodies
- introduce tag and probe components for aptamer immobilization
- describe tag characteristics
- describe probe characteristics
- discuss aptamer immobilization on beads
- describe aptamer-based cell enrichment method
- discuss advantages of aptamer-based cell enrichment
- provide example of aptamer-based cell enrichment
- describe aptamer-based cell enrichment for therapeutic use
- discuss importance of rapid aptamer-based cell enrichment
- conclude aptamer section

### III. Devices for Enrichment of Cells

- describe device for enriching cell population with cells expressing cell surface marker
- specify aptamer capable of specifically binding cell surface marker
- couple aptamer to solid support, e.g., beads
- describe filter containing pore size smaller than bead diameter and larger than cell diameter
- describe column containing beads and filter
- specify syringe fitting for column
- specify centrifuge tube housing column
- describe production of cell population enriched for cells expressing cell surface marker
- list cell surface markers suitable for use in invention
- specify beads packed in column
- specify beads in suspension collected by centrifugation
- describe column size and character
- specify filter pore size
- describe separation of cells from beads using mechanical forces
- describe release of captured cells using temperature change
- describe release of captured cells using complementary nucleic acid
- describe aptamer coupling to solid support
- specify non-covalent coupling of aptamer to beads
- specify covalent coupling of aptamer to beads
- describe aptamer concentration on beads
- describe loading aptamer on beads
- describe recovery of selected cells from beads
- describe separation of cells through filter
- describe collection of recovered cells
- describe enrichment of cells expressing cell surface marker
- describe use of mixture of aptamer-coupled and aptamer-free beads
- specify ratio of aptamer-coupled to aptamer-free beads
- describe portable device
- describe closed system device
- describe prepackaged device in sterile container
- describe administration of enriched cells to subject
- describe administration of enriched cells at site of injury
- describe administration of enriched cells by injection
- describe use of antigen binding moiety other than aptamer
- describe device for enriching live cells from mixed cell population

### IV. Methods of Enriching Cells from a Mixed Cell Population

- provide methods for enriching cells
- involve aptamer-coupled beads
- contact aptamer-coupled beads with mixed cell population
- wash unbound cells
- subject beads to mechanical force
- release bound cells
- recover enriched cell population
- produce cell population enriched in cells expressing cell surface marker
- allow aptamer-coupled beads to remain in contact with mixed cell population
- specify time of incubation
- relate time of incubation to temperature
- specify temperatures for binding
- provide examples of cell surface markers
- specify CD31 as cell surface marker
- release cells using mechanical forces
- release cells using change in temperature
- release cells using nucleic acid molecule
- use temperature and/or complementary nucleic acid
- perform method using any embodiment of device
- specify size of beads
- specify composition of beads
- provide examples of beads
- specify non-magnetic beads
- use larger and non-magnetic beads
- isolate cells free or substantially free of beads and aptamer
- specify aptamer suitable for specifically binding cell surface marker
- couple aptamer to beads
- non-covalently couple aptamer to beads
- covalently couple aptamer to beads
- specify concentration of aptamer
- load aptamer on beads
- use mixture of beads coupled to aptamer and beads not coupled to aptamer
- specify ratios of aptamer-coupled beads to aptamer-free beads
- recover cells from aptamer-coupled beads
- pass cells through filter
- collect cells by centrifugation
- perform method in absence of antibody specific for cell surface marker
- enrich and/or isolate cells from whole blood sample
- enrich and/or isolate cells from peripheral blood mononuclear cell sample
- enrich and/or isolate cells from bone marrow sample
- enrich and/or isolate cells from tissue sample
- enrich and/or isolate cells from fluid sample
- perform enrichment method in short duration of time
- obtain cell sample from subject
- administer enriched or isolated cell population to subject

### V. Kits

- introduce kits for cell enrichment
- describe portable column components
- define portable column characteristics
- specify column volume options
- describe filter characteristics
- outline kit components for cell collection
- describe bead characteristics
- specify bead-to-aptamer ratios
- describe resuspension buffer options
- outline uses of isolated cells

### VI. Methods of Treatment

- provide cell-based therapy
- administer cells expressing cell surface marker
- enrich cells with aptamer-coupled beads
- wash beads with wash buffer
- release cells from beads
- recover cells with cell surface marker
- introduce cells at surgical site
- administer cell population enriched for cells with cell surface marker
- perform method intraoperatively
- perform method perioperatively or postoperatively
- enrich cells from whole blood sample
- enrich cells from peripheral blood mononuclear cell sample
- enrich cells from bone marrow sample
- enrich cells from hematoma sample
- enrich cells from tissue sample
- enrich cells from fluid sample
- obtain cell sample from subject
- promote angiogenesis
- promote osteogenesis
- promote immunomodulation
- treat bone fractures
- define angiogenesis-related diseases
- define osteogenesis-related diseases
- define bone fracture
- list conditions leading to bone fracture
- define immunomodulation-related diseases
- list diseases benefiting from immunomodulation
- define treat
- describe benefits of treatment
- list diseases that may be treated
- describe angiogenesis-related diseases
- describe osteogenesis-related diseases
- describe immunomodulation-related diseases
- list additional diseases that may be treated
- conclude methods of treatment
- introduce methods of treatment
- describe ischemic diseases
- motivate cell surface marker
- formulate cells with carrier
- describe biodegradable scaffold
- outline administration methods
- detail injection methods
- discuss cell sources
- determine therapeutically effective dosage
- describe target hematocrit range
- outline additional treatment methods
- clarify range notation
- preview examples

## EXAMPLES

### Materials and methods

- prepare PBMCs
- validate aptamer specificity
- perform magnetic bead studies
- analyze cell populations using flow cytometry
- assemble system for cell enrichment
- isolate CD31+ cells using system
- prepare conditioned medium
- assess angiogenic potential
- assess osteogenic potential
- prepare aptamer coated beads
- optimize ligand concentration
- analyze cell adhesion and release
- validate aptamer specificity using flow cytometry
- evaluate aptamer capacity to concentrate CD31+ cells
- benchmark aptamer-based isolation to commercial antibody isolation
- summarize aptamer validation results

### Aptamer Selection and Validation

- perform 2D cell adhesion assay
- optimize ligand concentration
- analyze cell adhesion and release
- validate aptamer specificity using flow cytometry
- evaluate aptamer capacity to concentrate CD31+ cells
- benchmark aptamer-based isolation to commercial antibody isolation
- summarize aptamer validation results
- analyze aptamer specificity and sensitivity
- evaluate aptamer capacity to capture and release CD31+ cells
- compare aptamer to anti-CD31 antibody
- validate aptamer for CD31+ cell enrichment

### Development of a CD31+ Cell Enrichment System

- outline system design
- describe system characteristics
- prepare bead suspension
- coat beads with aptamer
- assemble system
- optimize enrichment procedure
- evaluate effect of aptamer concentration on yield and viability
- evaluate effect of DNAse 1 on cell viability
- optimize bead ratio and number
- evaluate effect of bead volume on yield
- summarize system optimization results
- describe final system configuration
- discuss system flexibility for different aptamers

### CD31+ Enriched Cell Populations

- validate system for CD31+ cell enrichment
- isolate peripheral blood mononuclear cells
- prepare bead suspensions
- perform aptamer-based cell separation
- analyze enriched cell populations
- evaluate cell viability and enrichment

### Angiogenic and Osteogenic Potential of CD31+ Enriched Cell Populations

- assess angiogenic potential using tube formation assay
- prepare cell suspension and Matrigel
- perform tube formation assay
- evaluate total length of network
- assess osteogenic potential using Alizarin red staining
- prepare mesenchymal stromal cells
- induce osteogenic differentiation
- perform Alizarin red staining
- evaluate calcification
- demonstrate retention of angiogenic and osteogenic potential
- discuss use of CD31+ enriched cells
- introduce tissue waste as a source for CD31+ cell enrichment
- collect and process suction waste
- analyze composition of liquid and tissue samples
- evaluate CD31+ cell composition
- quantify CD45+ cells
- determine CD31+ levels among leukocytes
- discuss use of tissue and liquid samples as a source of CD31+ cells
- introduce discussion section
- evaluate cell sorting strategy
- discuss aptamer-based cell isolation
- compare to commercial approaches
- discuss therapeutic potential of devices

## EQUIVALENTS

- disclaim limitations

